Omnia Family Wealth, LLC Akari Therapeutics PLC Transaction History

Omnia Family Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$0.6 - $12.6 $14,536 - $305,272	24,228 Added 3.2%	782,372 $493,000
Q1 2022 May 06, 2022	BUY	$1.09 - $1.53 $99,254 - $139,320	91,059 Added 13.65%	758,144 $910,000
Q4 2021 Feb 04, 2022	BUY	$1.38 - $1.74 $276,000 - $348,000	200,000 Added 42.82%	667,085 $1 Million
Q2 2021 Aug 03, 2021	BUY	$1.69 - $2.85 $85,346 - $143,927	50,501 Added 12.12%	467,085 $808,000
Q1 2021 May 12, 2021	BUY	$1.81 - $3.88 $45,250 - $97,000	25,000 Added 6.38%	416,584 $1.1 Million
Q2 2020 Aug 04, 2020	BUY	$1.16 - $2.61 $240,498 - $541,120	207,326 Added 112.52%	391,584 $853,000
Q1 2020 May 05, 2020	BUY	$1.06 - $2.16 $15,470 - $31,525	14,595 Added 8.6%	184,258 $267,000
Q4 2019 Feb 05, 2020	BUY	$1.69 - $2.16 $286,730 - $366,472	169,663 New	169,663 $297,000

Ticker AKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,349,200
Market Cap $123M
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...

Get notified when there are updates to the investment portfolio of Omnia Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Omnia Family Wealth, LLC with notifications on news.